Publications by authors named "Peter Markus"

Claim this Profile
D
Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer.
Lisa Veghini, Davide Pasini, Rui Fang, Pietro Delfino, Dea Filippini, Peter Markus

Nat Commun· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapy.
Vivian Rosery, Stephan Mika, Kurt Werner Schmid, Henning Reis, Martin Stuschke, Peter Markus

J Cancer Res Clin Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcome and Treatment Sequences of Patients with Advanced Pancreatic Cancer Treated with Contemporary Chemotherapy Protocols.
Julius Roehrle, Stefan Kasper, Jürgen-Walter Treckmann, Peter Markus, Brigitte Schumacher, Maximilian Markus

Oncol Res Treat· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Study of Nab-Paclitaxel and Gemcitabine as First-Line Therapy in Patients with Cholangiocarcinoma Ineligible for Cisplatin-Based Chemotherapy (NACHO).
Isabel Virchow, Jürgen-Walter Treckmann, Nicole Prasnikar, Gabriele Linden, Peter Markus

Oncol Res Treat· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer.
Julius Keyl, René Hosch, Aaron Berger, Oliver Ester, Tobias Greiner, Peter Markus

J Cachexia Sarcopenia Muscle· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression.
Phyllis F Cheung, JiaJin Yang, Rui Fang, Arianna Borgers, Kirsten Krengel, Peter Markus

Nat Commun· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer: The CEBIFOX Trial.
Stefan Kasper, Johannes Meiler, Heike Knipp, Thomas Höhler, Peter Reimer, Peter Markus

Clin Colorectal Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of RAS mutation subtype on clinical outcome-a cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancer.
Marcel Wiesweg, Stefan Kasper, Karl Worm, Thomas Herold, Henning Reis, Peter Markus

Oncogene· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Giant Intraductal Papillary Mucinous Neoplasia (IPMN) of the Pancreas with Malignant Degeneration.
Kai Nassenstein, Peter Markus, Brigitte Schumacher

Dtsch Arztebl Int· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive mapping before surgical ablation for persistent, long-standing atrial fibrillation.
Marek P Ehrlich, Guenther Laufer, Iuliana Coti, Markus Peter, Martin Andreas

J Thorac Cardiovasc Surg· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal Cancer.
Marcel Wiesweg, Henning Reis, Tobias Köster, Moritz Goetz, Karl Worm, Peter Markus

Clin Colorectal Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer Center.
Marcel Wiesweg, Saskia Ting, Henning Reis, Karl Worm, Stefan Kasper, Peter Markus

Eur J Cancer· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nondestructive characterization of nanoscale layered samples.
Olaf Baake, Peter S Hoffmann, Stefan Flege, Hugo M Ortner, Sebastian Gottschalk, Markus Peter

Anal Bioanal Chem· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of carcinoembryonic antigen radioimmunotherapy with 131I-labetuzumab after salvage resection of colorectal metastases in the liver: five-year safety and efficacy results.
Torsten Liersch, Johannes Meller, Bettina Kulle, Thomas M Behr, Peter Markus

J Clin Oncol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver repopulation after hepatocellular transplantation: integration and interaction of transplanted hepatocytes in the host.
Sarah Koenig, Claudia Stoesser, Petra Krause, Heinz Becker, Peter M Markus

Cell Transplant· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Significance of isolated tumor cells in lymph nodes among gastric cancer patients.
Olaf Horstmann, Laszlo Füzesi, Peter M Markus, Carola Werner, Heinz Becker

J Cancer Res Clin Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pylorus preservation has no impact on delayed gastric emptying after pancreatic head resection.
Olaf Horstmann, Peter M Markus, Michael B Ghadimi, Heinz Becker

Pancreas· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vasoactive intestinal polypeptide and gastrin-releasing peptide attenuate hepatic microvasculatory disturbances following intestinal ischemia and reperfusion.
Ingo Leister, Ebenzar M Mbachu, Stefan Post, Stefan T Samel, Tomislav Stojanovic, Peter M Markus

Digestion· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo design, synthesis and evaluation of a non-steroidal diphenylnaphthyl propylene ligand for the estrogen receptor.
Jonathan M Schmidt, Julie Mercure, Gilles B Tremblay, Martine Pagé, Miklos Feher, Markus G Peter

Bioorg Med Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and evaluation of a novel nonsteroidal-specific endothelial cell proliferation inhibitor.
Jonathan M Schmidt, Gilles B Tremblay, Martine Pagé, Julie Mercure, Miklos Feher, Markus G Peter

J Med Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
De novo design, synthesis, and evaluation of novel nonsteroidal phenanthrene ligands for the estrogen receptor.
Jonathan M Schmidt, Julie Mercure, Gilles B Tremblay, Martine Pagé, Aida Kalbakji, Markus G Peter

J Med Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Met-RANTES inhibition of mucosal perfusion failure in acute intestinal transplant rejection - role of endothelial cell-leukocyte interaction.
Tomislav Stojanovic, Jens Bedke, Hermann-Josef Gröne, Amanda E I Proudfoot, Heinz Becker, Peter Markus, Markus Hecker

J Vasc Res· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radioimmunotherapy of small-volume disease of metastatic colorectal cancer.
Thomas M Behr, Torsten Liersch, Lutz Greiner-Bechert, Frank Griesinger, Martin Béhé, Peter M Markus

Cancer· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis